Skip to main content
Erschienen in: Neuroradiology 8/2008

01.08.2008 | Interventional Neuroradiology

Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience

verfasst von: W. Kurre, J. Berkefeld, M. Sitzer, T. Neumann-Haefelin, R. du Mesnil de Rochemont

Erschienen in: Neuroradiology | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

We report our first clinical experience with a CE-marked flexible monorail balloon-expandable stent for treatment of high-grade intracranial stenoses.

Methods

Between April 2006 and November 2007 21 patients with symptomatic intracranial stenoses (>70%) were treated with the PHAROS stent. In seven patients, the procedure was performed during acute stroke intervention. Procedural success, clinical complication rates and mid-term follow-up data were prospectively recorded.

Results

During a median follow-up period of 7.3 months one additional patient died of an unknown cause 3 months after the intervention. A patient with a significant residual stenosis presented with a new stroke after further progression of the residual stenosis. None of the successfully treated patients experienced ipsilateral stroke.

Conclusion

Recanalization of intracranial stenoses with the balloon-expandable Pharos stent is technically feasible. The periprocedural complication rate and mid-term follow-up results were in the range of previously reported case series. This pilot study was limited by the small sample size and severe morbidity of the included patients. Final evaluation of the efficacy of Pharos stent treatment demands further investigation.
Literatur
1.
Zurück zum Zitat Meyers PM, Schumacher HC, Tanji K, Higashida RT, Caplan LR (2007) Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 58:107–122PubMedCrossRef Meyers PM, Schumacher HC, Tanji K, Higashida RT, Caplan LR (2007) Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 58:107–122PubMedCrossRef
2.
Zurück zum Zitat Higashida RT, Meyers PM, Connors JJ 3rd, Sacks D, Strother CM, Barr JD, Wojak JC, Duckwiler GR; American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Society of Neuroradiology (2005) Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol 26:2323–2327PubMed Higashida RT, Meyers PM, Connors JJ 3rd, Sacks D, Strother CM, Barr JD, Wojak JC, Duckwiler GR; American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, American Society of Neuroradiology (2005) Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol 26:2323–2327PubMed
3.
Zurück zum Zitat Berkefeld J, Hammann GF, du Mesnil R, Kurre W, Steinmetz H, Zanella FE, Sitzer M (2006) Endovascular treatment for intracranial stenoses – a common statement by neurologists and neuroradiologists. Nervenarzt 77(12):1444–1455PubMedCrossRef Berkefeld J, Hammann GF, du Mesnil R, Kurre W, Steinmetz H, Zanella FE, Sitzer M (2006) Endovascular treatment for intracranial stenoses – a common statement by neurologists and neuroradiologists. Nervenarzt 77(12):1444–1455PubMedCrossRef
4.
Zurück zum Zitat SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35:1388–1392CrossRef SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35:1388–1392CrossRef
5.
Zurück zum Zitat du Mesnil de Rochemont, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J (2004) Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents – initial experience. Radiology 231:45–49CrossRef du Mesnil de Rochemont, Turowski B, Buchkremer M, Sitzer M, Zanella FE, Berkefeld J (2004) Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents – initial experience. Radiology 231:45–49CrossRef
6.
Zurück zum Zitat Weber W, Mayer TE, Henkes H, Kis B, Hamann GF, Schulte-Altedornenburg G, Brückmann H, Kuehne D (2005) Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol 55:231–236PubMedCrossRef Weber W, Mayer TE, Henkes H, Kis B, Hamann GF, Schulte-Altedornenburg G, Brückmann H, Kuehne D (2005) Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol 55:231–236PubMedCrossRef
7.
Zurück zum Zitat Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT (2005) Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 64:1055–1057PubMed Yu W, Smith WS, Singh V, Ko NU, Cullen SP, Dowd CF, Halbach VV, Higashida RT (2005) Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 64:1055–1057PubMed
8.
Zurück zum Zitat Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA (2005) Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 26(4):869–874PubMed Chow MM, Masaryk TJ, Woo HH, Mayberg MR, Rasmussen PA (2005) Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 26(4):869–874PubMed
9.
Zurück zum Zitat Abou-Chebl A, Krieger DW, Gajzer CT, Yadav JS (2006) Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 16(3):216–223PubMed Abou-Chebl A, Krieger DW, Gajzer CT, Yadav JS (2006) Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 16(3):216–223PubMed
10.
Zurück zum Zitat Lylyk P, Vila JF, Miranda C, Ferrario A, Musacchio A, Rüfenacht D, Cohen JE (2005) Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 27 [Suppl 1]:S84–S88PubMedCrossRef Lylyk P, Vila JF, Miranda C, Ferrario A, Musacchio A, Rüfenacht D, Cohen JE (2005) Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 27 [Suppl 1]:S84–S88PubMedCrossRef
11.
Zurück zum Zitat Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT (2006) Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868–1872PubMedCrossRef Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT (2006) Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868–1872PubMedCrossRef
12.
Zurück zum Zitat Jiang WJ, Du B, Leung TW, Xu XT, Jin M, Dong KH (2007) Symptomatic intracranial stenoses: cerebrovascular complications from elective stent placement. Radiology 243(1):188–197PubMedCrossRef Jiang WJ, Du B, Leung TW, Xu XT, Jin M, Dong KH (2007) Symptomatic intracranial stenoses: cerebrovascular complications from elective stent placement. Radiology 243(1):188–197PubMedCrossRef
13.
Zurück zum Zitat Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N (2007) Comparison of elective stenting of severe versus moderate intracranial atherosclerotic stenosis. Neurology 68:420–426PubMedCrossRef Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N (2007) Comparison of elective stenting of severe versus moderate intracranial atherosclerotic stenosis. Neurology 68:420–426PubMedCrossRef
14.
Zurück zum Zitat Fiorella D, Chow MM, Anderson M, Woo H, Rassmussen PA, Masaryk TJ (2007) A 7-year experience with balloon mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61:236–243PubMedCrossRef Fiorella D, Chow MM, Anderson M, Woo H, Rassmussen PA, Masaryk TJ (2007) A 7-year experience with balloon mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61:236–243PubMedCrossRef
15.
Zurück zum Zitat Levy EI, Turk A, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rassmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ (2007) Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61:644–651PubMedCrossRef Levy EI, Turk A, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rassmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ (2007) Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 61:644–651PubMedCrossRef
16.
Zurück zum Zitat Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chatuverdi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563PubMedCrossRef Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chatuverdi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563PubMedCrossRef
17.
Zurück zum Zitat Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F (2006) Prospective study of symptomatic atherothrombotic intracranial stenoses – the GESICA study. Neurology 66:1187–1191PubMedCrossRef Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F (2006) Prospective study of symptomatic atherothrombotic intracranial stenoses – the GESICA study. Neurology 66:1187–1191PubMedCrossRef
18.
Zurück zum Zitat Thijs VN, Alberts GW (2000) Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55(4):490–497PubMed Thijs VN, Alberts GW (2000) Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55(4):490–497PubMed
19.
Zurück zum Zitat Henkes H, Miloslavki E, Lowens S, Reinatz J, Liebig T, Kühne D (2005) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47:222–228PubMedCrossRef Henkes H, Miloslavki E, Lowens S, Reinatz J, Liebig T, Kühne D (2005) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47:222–228PubMedCrossRef
20.
Zurück zum Zitat Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP (2007) A novel, self expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses. Stroke 38:1531–1537PubMedCrossRef Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP (2007) A novel, self expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses. Stroke 38:1531–1537PubMedCrossRef
21.
Zurück zum Zitat Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, Raupp E, Hidalgo R, Pieruccetti MA (2007) Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol 68:378–386PubMedCrossRef Freitas JM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, Raupp E, Hidalgo R, Pieruccetti MA (2007) Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol 68:378–386PubMedCrossRef
22.
Zurück zum Zitat Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21(4):643–646PubMed Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21(4):643–646PubMed
24.
Zurück zum Zitat Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2008) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 29:281–285PubMed Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2008) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 29:281–285PubMed
26.
Zurück zum Zitat Levy EI, Metha R, Gupta R, Hanel RA, Chamzuk AJ, Fiorella D, Woo HH, Albuquerque FC, Jovin TG, Horowitz MB, Hopkins LN (2007) Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 28(5):816–822PubMed Levy EI, Metha R, Gupta R, Hanel RA, Chamzuk AJ, Fiorella D, Woo HH, Albuquerque FC, Jovin TG, Horowitz MB, Hopkins LN (2007) Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 28(5):816–822PubMed
Metadaten
Titel
Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience
verfasst von
W. Kurre
J. Berkefeld
M. Sitzer
T. Neumann-Haefelin
R. du Mesnil de Rochemont
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 8/2008
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-008-0394-6

Weitere Artikel der Ausgabe 8/2008

Neuroradiology 8/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.